|Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review|
BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ...
The Lancet 372 (9651), 1733-1745, 2008
|The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic|
JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan
The Lancet 368 (9534), 531-536, 2006
|Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work|
K Shannon, T Kerr, S Allinott, J Chettiar, J Shoveller, MW Tyndall
Social science & medicine 66 (4), 911-921, 2008
|Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic|
MW Tyndall, S Currie, P Spittal, K Li, E Wood, MV O'Shaughnessy, ...
Aids 17 (6), 887-893, 2003
|Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers|
K Shannon, T Kerr, SA Strathdee, J Shoveller, JS Montaner, MW Tyndall
Bmj 339, b2939, 2009
|Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy|
K Shannon, SA Strathdee, J Shoveller, M Rusch, T Kerr, MW Tyndall
American journal of public health 99 (4), 659-665, 2009
|Safer injection facility use and syringe sharing in injection drug users|
T Kerr, M Tyndall, K Li, J Montaner, E Wood
The Lancet 366 (9482), 316-318, 2005
|Hospital utilization and costs in a cohort of injection drug users|
A Palepu, MW Tyndall, H Leon, J Muller, MV O'Shaughnessy, ...
Cmaj 165 (4), 415-420, 2001
|Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users|
E Wood, T Kerr, W Small, K Li, DC Marsh, JSG Montaner, MW Tyndall
Cmaj 171 (7), 731-734, 2004
|Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection|
DM Patrick, MW Tyndall, PGA Cornelisse, K Li, CH Sherlock, ML Rekart, ...
Cmaj 165 (7), 889-895, 2001
|Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver|
PM Spittal, KJP Craib, E Wood, N Laliberté, K Li, MW Tyndall, ...
Cmaj 166 (7), 894-899, 2002
|Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users|
T Kerr, N Fairbairn, M Tyndall, D Marsh, K Li, J Montaner, E Wood
Drug and alcohol dependence 87 (1), 39-45, 2007
|Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?|
E Wood, MW Tyndall, PM Spittal, K Li, T Kerr, RS Hogg, JSG Montaner, ...
Cmaj 165 (4), 405-410, 2001
|Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America|
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
|Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users|
E Wood, JSG Montaner, B Yip, MW Tyndall, MT Schechter, ...
Cmaj 169 (7), 656-661, 2003
|Mapping violence and policing as an environmental–structural barrier to health service and syringe availability among substance-using women in street-level sex work|
K Shannon, M Rusch, J Shoveller, D Alexson, K Gibson, MW Tyndall
International Journal of Drug Policy 19 (2), 140-147, 2008
|Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver|
KJP Craib, PM Spittal, E Wood, N Laliberte, RS Hogg, K Li, K Heath, ...
Cmaj 168 (1), 19-24, 2003
|Summary of findings from the evaluation of a pilot medically supervised safer injecting facility|
E Wood, MW Tyndall, JS Montaner, T Kerr
Cmaj 175 (11), 1399-1404, 2006
|Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy|
A Palepu, MW Tyndall, R Joy, T Kerr, E Wood, N Press, RS Hogg, ...
Drug and alcohol dependence 84 (2), 188-194, 2006
|Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy|
DM Moore, RS Hogg, B Yip, E Wood, M Tyndall, P Braitstein, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 288-293, 2005